Simulated treatment comparison of efficacy outcomes for ofatumumab in ASCLEPIOS I/II versus ocrelizumab in OPERA I/II for the treatment of patients with relapsing multiple sclerosis
| Autor: | Samjoo, Imtiaz A., Klotz, Luisa, Giovannoni, Gavin, Drudge, Christopher, Haltner, Anja, Worthington, Evelyn, Zhao, Melody, Brennan, Róisín, Häring, Dieter A., Cameron, Chris, Adlard, Nicholas |
|---|---|
| Zdroj: | In Multiple Sclerosis and Related Disorders October 2022 66 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect